Citations

Showing 10 of 108152 citations.

Research Is the Key to Success in Plastic Surgery
Huayllani, María T. , Restrepo, David J. , Oliver, Jeremie D. , Rinker, Brian, Forte, Antonio J. , Boczar, Daniel , Rinker, Brian D, Forte, Antonio Jorge , Oliver, Jeremie D , Sisti, Andrea

Mayo Clinic

Plastic & Reconstructive Surgery | September 14, 2019 | Volume: 145 | Issue: 1 | Pages: 222e-224e

10.1097/prs.0000000000006241 | PMID 31524805 Get It

An Analysis of Differences in the Number of Children for Female and Male Plastic Surgeons
Eells, Annica C. , Khan, Nawal , Huayllani, María T. , Forte, Antonio J. , Forte, Antonio Jorge

Mayo Clinic

Plastic & Reconstructive Surgery | September 14, 2019 | Volume: 145 | Issue: 1 | Pages: 219e-220e

10.1097/prs.0000000000006240 | PMID 31524810 Get It

Long-Term Outcomes for Adult Patients With Cleft Lip and Palate
Connolly, Katharine A., Kurnik, Nicole M. , Truong, Tuan, Müller, Cristiane , Beals, Patricia, Singh, Davinder , Beals, Stephen P., Truong, Tuan A, Singh, Davinder J , Muller, Cristiane

Mayo Clinic

Journal of Craniofacial Surgery | September 14, 2019 | Volume: 30 | Issue: 7 | Pages: 2048-2051

10.1097/scs.0000000000005932 | PMID 31524752 Get It

Abstract The purpose of this study was to evaluate a single center's experience with adult patients who had cleft lip, cleft palate, or both. The authors aimed to identify common long-term needs in this patient population and evaluated the relationship of team-based care in meeting those needs. To do so, the authors retrospectively reviewed chart records from a single private practice and tertiary referral cleft center for all patients who were ≥15 years of age and who had a history of clefts of the lip or palate, or both, from January 1, 2013, to June 30, 2014. The authors compared the concerns of the patients who received cleft-team–based care by a single, multidisciplinary cleft team; multiple multidisciplinary cleft teams; or no formal cleft team. The authors analyzed data for 142 patients. The most common patient concerns were lip aesthetics (64%), nose aesthetics (61%), septal deviations (47%), nasal obstruction (44%), malocclusion (32%), oronasal fistulas (29%), and speech (21%). Oronasal fistulas were more commonly reported in the group of patients who had care by multiple teams (42.9%; P < .001). Malocclusion was more commonly reported in the group of patients who had care by multiple teams (50%; P = .001). The authors found that adult patients who have undergone rehabilitation for cleft lip and palate appear to have a common set of long-term needs. Multidisciplinary cleft-team–based care appears to be the most effective way to address these needs.
Benign notochordal cell tumor of the clivus with chordoma component: report of 2 cases
Peris‐Celda, Maria , Salgado-López, Laura , Inwards, Carrie Y., Janus, Jeffrey R. , Stokken, Janalee K., Raghunathan, Aditya , Carr, Carrie M. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | September 14, 2019 | Volume: 133 | Issue: 5 | Pages: 1355-1359

10.3171/2019.6.jns19529 | PMID 31518983 Get It

Benign notochordal cell tumors (BNCTs) are considered to be benign intraosseous lesions of notochord origin; however, recent spine studies have suggested the possibility that some chordomas arise from BNCTs. Here, the authors describe two cases demonstrating histological features of BNCT and concomitant chordoma involving the clivus, which, to the best of the authors’ knowledge, have not been previously documented at this anatomical site.An 18-year-old female presented with an incidentally discovered clival mass. Magnetic resonance imaging revealed a 2.8-cm nonenhancing lesion in the upper clivus that was T2 hyperintense and T1 hypointense. She underwent an uneventful endoscopic transsphenoidal resection. Histologically, the tumor demonstrated areas of classic chordoma and a distinct intraosseous BNCT component. The patient completed adjuvant radiation therapy. Follow-up showed no recurrence at 18 months.A 39-year-old male presented with an incidentally discovered 2.8-cm clival lesion. The nonenhancing mass was T2 hyperintense and T1 hypointense. Surgical removal of the lesion was performed through an endoscopic transsphenoidal approach. Histological analysis revealed areas of BNCT with typical features of chordoma. Follow-up did not demonstrate recurrence at 4 years.These cases document histologically concomitant BNCT and chordoma involving the clivus, suggesting that the BNCT component may be a precursor of chordoma.
Periprocedural intracranial hemorrhage after embolization of cerebral arteriovenous malformations: a meta-analysis
Subat, Yosuf W., Dasenbrock, Hormuzdiyar H. , Gross, Bradley A. , Patel, Nirav J. , Frerichs, Kai U., Aziz‐Sultan, Mohammad Ali , Gross, Bradley , Du, Rose

Mayo Clinic

Journal of Neurosurgery | September 14, 2019 | Volume: 133 | Issue: 5 | Pages: 1417-1427

10.3171/2019.5.jns183204 | PMID 31518979 Get It

OBJECTIVEThe primary goal of the treatment of cerebral arteriovenous malformations (AVMs) is angiographic occlusion to eliminate future hemorrhage risk. Although multimodal treatment is increasingly used for AVMs, periprocedural hemorrhage after transarterial embolization is a potential endovascular complication that is only partially understood and merits quantification.METHODSSearching the period between 1990 and 2019, the authors of this meta-analysis queried the PubMed and Embase databases for studies reporting periprocedural hemorrhage (within 30 days) after liquid embolization (using cyanoacrylate or ethylene vinyl alcohol copolymer) of AVMs. Random effects meta-analysis was used to evaluate the pooled rate of flow-related hemorrhage (those attributed to alterations in AVM dynamics), technical hemorrhage (those related to procedural complications), and total hemorrhage. Meta-regression was used to analyze the study-level predictors of hemorrhage, including patient age, Spetzler-Martin grade, hemorrhagic presentation, embolysate used, intent of treatment (adjuvant vs curative), associated aneurysms, endovascular angiographic obliteration, year of study publication, and years the procedures were performed.RESULTSA total of 98 studies with 8009 patients were included in this analysis, and the mean number of embolization sessions per patient was 1.9. The pooled flow-related and total periprocedural hemorrhage rates were 2.0% (95% CI 1.5%–2.4%) and 2.6% (95% CI 2.1%–3.0%) per procedure and 3.4% (95% CI 2.6%–4.2%) and 4.8% (95% CI 4.0%–5.6%) per patient, respectively. The mortality and morbidity rates associated with hemorrhage were 14.6% and 45.1%, respectively. Subgroup analyses revealed a pooled total hemorrhage rate per procedure of 1.8% (95% CI 1.0%–2.5%) for adjuvant (surgery or radiosurgery) and 4.6% (95% CI 2.8%–6.4%) for curative intent. The treatment of aneurysms (p = 0.04) and larger patient populations (p < 0.001) were significant predictors of a lower hemorrhage rate, whereas curative intent (p = 0.04), angiographic obliteration achieved endovascularly (p = 0.003), and a greater number of embolization sessions (p = 0.03) were significant predictors of a higher hemorrhage rate. There were no significant differences in periprocedural hemorrhage rates according to the years evaluated or the embolysate utilized.CONCLUSIONSIn this study-level meta-analysis, periprocedural hemorrhage was seen after 2.6% of transarterial embolization procedures for cerebral AVMs. The adjuvant use of endovascular embolization, including in the treatment of associated aneurysms and in the presurgical or preradiosurgical setting, was a study-level predictor of significantly lower hemorrhage rates, whereas more aggressive embolization involving curative intent and endovascular angiographic obliteration was a predictor of a significantly higher total hemorrhage rate.
Tolerogenic Vaccination For Graves’ Disease — Targeting the Root of the Problem
Banga, JP, Stan, Marius N.

Mayo Clinic

Clinical Thyroidology | September 13, 2019 | Volume: 31 | Issue: 9 | Pages: 372-375

10.1089/ct.2019;31.372-375 Get It

PAPP-A and the IGF system in atherosclerosis: what’s up, what’s down?
Steffensen, Lasse Bach , Conover, Cheryl A. , Oxvig, Claus , Steffensen, Lasse B

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | September 13, 2019 | Volume: 317 | Issue: 5 | Pages: H1039-H1049

10.1152/ajpheart.00395.2019 | PMID 31518159 Get It

Pregnancy-associated plasma protein-A (PAPP-A) is a metalloproteinase with a well-established role in releasing bioactive insulin-like growth factor-1 (IGF-1) from IGF-binding protein-2, -4, and -5 by proteolytic processing of these. The IGF system has repeatedly been suggested to be involved in the pathology of atherosclerosis, and both PAPP-A and IGF-1 are proposed biomarkers and therapeutic targets for this disease. Several experimental approaches based on atherosclerosis mouse models have been undertaken to obtain causative and mechanistic insight to the role of these molecules in atherogenesis. However, reports seem conflicting. The literature suggests that PAPP-A is detrimental, while IGF-1 is beneficial. This raises important questions that need to be addressed. Here we summarize the various studies and discuss potential underlying explanations for this seemingly inconsistency with the objective of better understanding complexities and limitations when manipulating the IGF system in mouse models of atherosclerosis. A debate clarifying what’s up and what’s down is highly warranted going forward with the ultimate goal of improving atherosclerosis therapy by targeting the IGF system.
Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era
Taparra, Kekoa , Liu, Heshan , Polley, Mei‐Yin C. , Ristow, Kay M., Ansell, Stephen M. , Polley, Mei-Yin, Ristow, Kay, Habermann, Thomas M.

Mayo Clinic

Leukemia & Lymphoma | September 13, 2019 | Volume: 61 | Issue: 2 | Pages: 298-308

10.1080/10428194.2019.1663419 | PMID 31517559 Get It

Ongoing and Focused Provider Performance Evaluations in Emergency Medicine: Current Practices and Modified Delphi to Guide Future Practice
Walker, Laura , Phelan, Michael , Bitner, Matthew , Legome, Eric , Tomaszewski, Christian, Strauss, Robert W., Nestler, David M. , Walker, Laura E

Mayo Clinic

American Journal of Medical Quality | September 13, 2019 | Volume: 35 | Issue: 4 | Pages: 306-314

10.1177/1062860619874113 | PMID 31516026 Get It

The Joint Commission requires ongoing and focused provider performance evaluations (OPPEs/FPPEs). The authors aim to describe current approaches in emergency medicine (EM) and identify consensus-based best practice recommendations. An online survey was distributed to leaders in EM to gain insight into current practices. A modified Delphi approach was then used to develop consensus to recommend best practice. A variety of strategies are currently in use for OPPE/FPPE. “Peer reviewed cases with opportunity for improvement” was identified as a preferred metric for OPPE. Although the preference was for use of peer review in OPPE, a consistent and standard adoption of robust internal care review processes is needed to establish expected norms. National benchmarking is not available currently. This was a limited survey of self-identified leaders, and there is an opportunity for additional engagement of leaders in EM to identify a unified approach that appropriately relates to patient outcomes.
Bile duct involvement by hepatocellular carcinoma: A rare occurrence and poor prognostic indicator in bile duct brushing samples
Bhattarai, Shristi , Graham, Rondell P. , Shi, Jiaqi , Xue, Yue , HooKim, Kim, Adsay, Volkan , Reid, Michelle D. , Sigel, Carlie S , Reid, Michelle D , Graham, Rondell P , González, Raul S. , Krasinskas, Alyssa M. , Adsay, N Volkan

Mayo Clinic

Cancer Cytopathology | September 13, 2019 | Volume: 127 | Issue: 11 | Pages: 691-699

10.1002/cncy.22185 | PMID 31518056 Get It

BackgroundHepatocellular carcinoma (HCC) rarely involves the biliary tree and may be inadvertently sampled on bile duct brushings (BDBs).MethodsThe pathology archives of 5 institutions were searched for BDBs with HCC involvement.ResultsA total of 17 BDBs from 14 patients were obtained. There was a male:female ratio of 6:1; the median age of the patients was 59.5 years (range, 22‐80 years). The median hepatic tumor size was 6.2 cm (range, 2.2‐13.0 cm). HCC risk factors included viral hepatitis (5 patients), cirrhosis (5 patients), hemochromatosis (1 patient), and alcoholic steatohepatitis (1 patient). Jaundice with elevated bilirubin, liver enzymes, and α‐fetoprotein was common. Endoscopic retrograde cholangiopancreatography demonstrated bile duct dilatation, polypoid intraductal masses (5 samples), clots/debris (2 samples), or strictures (4 samples). All BDBs had single and clustered large cells with naked atypical nuclei, granular cytoplasm, high nuclear/cytoplasmic ratios, and nuclei with prominent macronucleoli. Less common findings included clear/microvesicular cytoplasm (35%), papillae (29%), and anisonucleosis (35%). Classic HCC features (widened trabeculae [35%], endothelial wrapping [24%], multinucleation [24%], and cytoplasmic bile pigment [35%]) were uncommon. A total of 11 BDBs were diagnosed as malignant (10 with HCC and 1 with cholangiocarcinoma), 2 were diagnosed as atypical, and 1 BDB was diagnosed as negative; approximately two‐thirds were found to have polysomy on fluorescence in situ hybridization. Approximately 71% of patients died of disease at a median of 3.5 months.ConclusionsHCC may extend into the intrahepatic and/or extrahepatic biliary tree, causing masses and/or strictures that may be sampled on BDB. Although cytologically malignant, the classic features of HCC are uncommon, which can cause misdiagnosis. Cytopathologists should be mindful of this differential when evaluating BDBs, particularly when concomitant liver masses and/or HCC risk factors are present. Because of the associated high mortality and rapid rate of death, its presence should be conveyed clearly in pathology reports.